Jeffrey Alan Jones

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Alan Jones:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Chief Medical Officer Common Stock 169,532 $1,639,374 $9.67 18 Dec 2025 Direct
Cullinan Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 130,000 19 Feb 2025 Direct

Insider Reports Filed by Jeffrey Alan Jones

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Therapeutics, Inc. 18 Dec 2025 1 -$44,791 4 Chief Medical Officer 19 Dec 2025, 17:00
CGEM Cullinan Therapeutics, Inc. 25 Feb 2025 1 -$41,754 4 Chief Medical Officer 27 Feb 2025, 17:00
CGEM Cullinan Therapeutics, Inc. 19 Feb 2025 2 $0 4 Chief Medical Officer 21 Feb 2025, 18:00
CGEM Cullinan Therapeutics, Inc. 18 Dec 2024 1 -$52,851 4 Chief Medical Officer 20 Dec 2024, 17:00
CGEM Cullinan Oncology, Inc. 22 Feb 2024 2 $0 4 Chief Medical Officer 23 Feb 2024, 17:00
CGEM Cullinan Oncology, Inc. 21 Dec 2023 1 -$15,810 4 Chief Medical Officer 22 Dec 2023, 17:30
CGEM Cullinan Oncology, Inc. 18 Dec 2023 1 -$3,173 4 Chief Medical Officer 20 Dec 2023, 18:00
CGEM Cullinan Oncology, Inc. 20 Jun 2023 1 -$5,008 4 Chief Medical Officer 21 Jun 2023, 16:17
CGEM Cullinan Oncology, Inc. 18 May 2023 1 -$3,451 4 Chief Medical Officer 19 May 2023, 16:46
CGEM Cullinan Oncology, Inc. 18 Apr 2023 1 -$4,198 4 Chief Medical Officer 20 Apr 2023, 16:38
CGEM Cullinan Oncology, Inc. 20 Mar 2023 1 -$4,415 4 Chief Medical Officer 27 Mar 2023, 16:05
CGEM Cullinan Oncology, Inc. 17 Feb 2023 2 $0 4 Chief Medical Officer 21 Feb 2023, 17:51
CGEM Cullinan Oncology, Inc. 28 Feb 2022 1 $0 4 Chief Medical Officer 02 Mar 2022, 18:05
CGEM Cullinan Oncology, Inc. 28 Feb 2022 0 $0 3 Chief Medical Officer 02 Mar 2022, 18:04